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Postnatal maturation of the neurons whose main phenotype and basic synaptic contacts
are already established includes neuronal growth, refinement of synaptic contacts, final
steps of differentiation, programmed cell death period (PCD) etc. In the sympathetic
neurons, postnatal maturation includes permanent end of the PCD that occurs with the
same time schedule in vivo and in vitro suggesting that the process could be genetically
determined. Also many other changes in the neuronal maturation could be permanent
and thus based on stable changes in the genome expression. However, postnatal
maturation of the neurons is poorly studied. Here we compared the gene expression
profiles of immature and mature sympathetic neurons using Affymetrix microarray assay.
We found 1310 significantly up-regulated and 1151 significantly down-regulated genes
in the mature neurons. Gene ontology analysis reveals up-regulation of genes related
to neuronal differentiation, chromatin and epigenetic changes, extracellular factors and
their receptors, and cell adhesion, whereas many down-regulated genes were related to
metabolic and biosynthetic processes. We show that termination of PCD is not related
to major changes in the expression of classical genes for apoptosis or cell survival. Our
dataset is deposited to the ArrayExpress database and is a valuable source to select
candidate genes in the studies of neuronal maturation. As an example, we studied the
changes in the expression of selected genes Igf2bp3, Coro1A, Zfp57, Dcx, and Apaf1
in the young and mature sympathetic ganglia by quantitative PCR and show that these
were strongly downregulated in the mature ganglia.
Keywords: sympathetic neurons, maturation, microarray, programmed cell death, nerve growth factor
Abbreviations:NGF, nerve growth factor; SCG, superior cervical ganglion; PCD, programmed cell death; NTF, neurotrophic
factor; FDR, false discovery rate; PCA, principle component analysis; GO, gene ontology; RT, reverse transcriptase; qPCR,
quantitative polymerase chain reaction; DIV, days in vitro.
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INTRODUCTION
Maturation of the neurons occurs when the differentiation
is mainly completed and the contacts with synaptic targets
are mostly established. It includes enlargement of cell soma,
strengthening of cytoskeleton, elaboration and refinement of
synaptic contacts and other final steps of differentiation. A
remarkable event in the maturating neuronal populations is the
programmed cell death (PCD) period, where many neurons die
apoptotically, thereby determining the final number of neurons
(Oppenheim, 1991). In the neurons that project out of the brain,
such as sensory, autonomic and spinal motoneurons the final
number is determined by the extent of trophic support provided
by target-derived neurotrophic factors (NTFs) that rescue the
neurons from apoptosis (Bibel and Barde, 2000; Huang and
Reichardt, 2001). The PCD lasts during a relatively short time
period and when it ends, the neurons are not apoptotic anymore
and do not require trophic support for survival. Compared
to the processes of the early neurogenesis, including the cell
fate determination, migration, and early differentiation of the
neurons during embryogenesis, the postnatal maturation of
neurons is poorly studied.
Sympathetic neurons of the superior cervical ganglion (SCG)
are one of the best studied models for neuronal development.
In mouse, the neural crest-derived precursors form the SCG
primordia between embryonic day (E) 11.5–14.5 (Nishino et al.,
1999). Most of SCG neurons become postmitotic before birth
of the animals (Hendry, 1977; Shi et al., 2008). The majority of
SCG neurons are noradrenergic and the main neurotransmitter-
synthesizing enzymes tyrosine hydroxylase and dopamine β
hydroxylase are expressed already in the early sympathetic
precursors (Pattyn et al., 1999). The neuritogenesis, target
innervation and synaptogenesis of the sympathetic neurons begin
in embryogenesis and continue after the birth (De Champlain
et al., 1970; Schotzinger and Landis, 1990). During postnatal
maturation, the somata of SCG neurons enlarge and synaptic
contacts with the targets are refined. The PCD period in SCG
neurons occurs during first two postnatal weeks when about
30% of the neurons die (Wright et al., 1983). Nerve growth
factor (NGF), secreted by the targets of innervation in the
limited amounts, rescues the neurons that get it (Harrington
and Ginty, 2013) whereas neurons that remain without NGF
die by unsuppressed apoptosis (Chang et al., 2002; Putcha and
Johnson, 2004; Kristiansen et al., 2011; Kristiansen and Ham,
2014). The PCD of the SCG neurons ends by about second
postnatal week and the neurons are then not dying any more in
the absence of NGF (Kole et al., 2013). How theNGF-dependency
disappears during maturation of SCG neurons is not known but
it occurs with the same time schedule both in vivo and in the
cultured neurons (Easton et al., 1997; Francis and Landis, 1999;
Putcha et al., 2000; Glebova and Ginty, 2005; Young et al., 2011)
and remains then a persistent trait, obviously via changes in
genome activity. Such stable changes in gene expression could
most probably be the basis for many other maturational events
as well. However, while the early specification and differentiation
of sympathetic neurons are extensively studied (Apostolova and
Dechant, 2009; Cane and Anderson, 2009; Young et al., 2011), the
postnatal maturation has deserved much less attention (Glebova
and Ginty, 2005; Kole et al., 2013).
Here we set up on search for significantly changed genes
during maturation of the SCG neurons. We compared by
microarray gene expression profile of the immature (5DIV—
days in vitro) and mature (21DIV) cultures of SCG neurons
from newbornmice. Our dataset is deposited to the ArrayExpress
database and is a valuable source to select candidate genes in the
studies of neuronal maturation. As an example, we studied the
changes in the expression of five genes that could be related to
neuronal maturation, by quantitative PCR (qPCR) on the whole
immature and mature SCG ganglia of mice and rats.
MATERIALS AND METHODS
Neuronal Cultures
All procedures for animal use were approved by the Estonian
Ethics Committee and University of Helsinki Laboratory Animal
Centre (Protocol number KEK11-020). SCG neurons from
newborn NMRI mice were prepared as described earlier (Yu
et al., 2003; Hellman et al., 2011; Jakobson et al., 2012, 2013).
The neurons were plated onto glass coverslips coated with type
IV collagen (BD Biosciences, San Diego, CA, USA, #354233)
and grown for 5DIV (immature) or 21DIV (mature) in the
Neurobasal medium (Invitrogen Ltd, UK) containing B27 serum
substitute (Invitrogen) and 30 ng/ml of NGF (PeproTech, Rocky
Hill, NJ, USA; #450-01). The culture medium was changed
twice a week. The neurons were harvested in phosphate-buffered
saline, pelleted and dissolved in the RNeasy RLT lysis buffer
(Qiagen, Venlo, Netherlands, #79216). Six independent cultures
for mature neurons and three independent cultures for immature
neurons (ganglia from 12 to 17 pups per culture) were prepared.
The majority of the non-neuronal cells were removed by pre-
plating step (Yu et al., 2003; Hellman et al., 2011; Jakobson
et al., 2012, 2013) but some always remained and proliferated.
The majority of these non-neuronal cells remained attached
to the glass coverslips after collection of the cells for RNA
extraction. However, to exclude genes of the non-neuronal cells
from the analysis with certainty we also collected non-neuronal
cells without neurons from the preplating step, that were grown
on the non-coated dishes in Neurobasal/B27 medium without
NGF for 5DIV and 21DIV, one sample for both. No neurons
remained alive in these conditions. To verify that the neurons
had indeed matured in vitro we tested whether the 21DIV
neurons have become independent of NGF for survival, a clear
hallmark of the mature SCG neurons. The 5DIV or 21DIV
cultures were washed three times with NGF-free medium and
function-blocking anti-NGF antibodies (Chemicon MAB5260Z)
were added. For comparison, the neurons were washed and re-
supplemented with NGF. The original number of living neurons
was counted under the inverted microscope immediately after
NGF deprivation and again 5 days later. The experiment was
repeated two times. On all repeats, all 21DIV neurons remained
alive for 5 additional DIV without or with NGF, as reported by
others (Easton et al., 1997; Putcha et al., 2000) whereas the 5DIV
neurons died by NGF deprivation as predicted (Yu et al., 2003;
Hellman et al., 2011; Mätlik et al., 2015) (not shown). Typical
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images are shown on Figure 1. The images were captured with
invertedmicroscope (model DM-IRB; Leica, Germany) usingHC
PL FLUOTAR objective (10×/0.30), and a 3CCD color video
camera (model DXC-950P; Sony) under the control of Image-
Pro Plus software version 3.0 (Media Cybernetics, Inc., Rockville,
MD, USA).
Array Hybridization
RNeasy Kit (Qiagen) was utilized for the purification of total
RNA. Cells were disrupted with lysis buffer and homogenized
passing the lysate through 20-gauge needle. 70% ethanol was
added and the sample was applied to an RNeasy spin column. The
RNA bound the membrane of the column and the contaminants
were washed away. Purified RNA was eluted in the water.
Sample RNAs were analyzed for integrity and quality on Agilent
Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA).
The labeling and hybridization were done using the Ambion
WT Expression Kit (Ambion, Austin, TX, USA) and Affymetrix
GeneChip WT Terminal Labeling Kit (Affymetrix, Santa Clara,
CA, USA), following the manufacturer’s instructions. The
starting amount of total RNA was 50 ng. 15µg of cRNA was used
for single-stranded cDNA-synthesis. A total of 5.5µg of single-
stranded cDNA was fragmented and hybridized onto a Mouse
Exon 1.0 ST Array (Affymetrix, Santa Clara, CA, USA) during
17-h incubation at 45◦C. Immediately following hybridization,
the array was processed using an automated protocol on the
GeneChip R© Fluidics Station 450, followed by scanning on a
GeneChip R© Scanner.
Microarray Data Analysis
Signal values were analyzed using Bioconductor (R). Re-
mapped gene annotations from the Brainarray Custom chip
description files were used (MoEx10stv1_Mm_ENSG, v.17.
1.0, http://brainarray.mbni.med.umich.edu/Brainarray/), and
additional gene information was extracted from EnsEMBL
using Biomart-package. Robust Multichip Average (RMA) was
used for background correction, quantile normalization and
summarization of the signal values. Gene expression values were
compared between the immature and mature neurons using the
moderated t-statistic of limma-package. Benjamini-Hochberg
(FDR) procedure was used for multiple testing correction. Genes
with FDR adjusted p < 0.05 and fold-change>2 were considered
FIGURE 1 | Neuronal cultures used for the microarray study. (A,B)
Images of typical 5DIV and 21DIV cultures of the SCG neurons taken before
cell collection. The 21DIV cultures contain many non-neuronal cells but most
of them remained attached to the glass surface after collection of the neurons.
Scale bar, 100µM.
significantly differentially expressed. List of these significantly
up- and down-regulated genes were used for gene ontology
enrichment analysis, which was performed with web-based
DAVID software (http://david.abcc.ncifcrf.gov/) (Huang da
et al., 2007).
Real-Time Quantitative PCR analysis
RNA from freshly prepared newborn, 14 days old and 21 days
old mouse and Sprague Dawley rat SCG, as well as from
total brain was purified with GeneElute Mammalian Total RNA
Miniprep kit (Sigma, St. Louis, MO, USA). DNase treatment
was done separately. RNA clean-up was done with the same
RNA purification kit. cDNA synthesis was performed in 20µl
reaction containing 4µl of 5x RT buffer (Solis Biodyne, Tartu,
Estonia), 2.5µl of 2.5mM mix of 4 dNTPs (Solis BioDyne),
1µl of Oligo (dT)18 primer (Thermo Fisher Scientific, Rockford,
IL, USA), 0.2µl of Random Hexamer Primer (Thermo Fisher
Scientific), 0.5µl of RiboLock RNase Inhibitor (Thermo Fisher
Scientific), 0.5µl of 200 U/µl MMLV Revertase RNase H minus
(Solis BioDyne) and 2µg of RNA in 11.3µl water. cDNA was
synthesized at 37◦C for 90min and kept thereafter for 5min at
95◦C to inactivate the polymerase. The whole reaction mixture
was diluted 2x with RNase-free water to standardize the cDNA
amount as 1µg of RNA in 20µl of cDNA synthesis reaction. The
quality of cDNA synthesis was estimated by PCR for cyclophilin
G expression.
qPCR analysis was done using Roche Light Cycler 480
II equipment (Roche, Penzberg, Germany). Ten µl reaction
mixture contained 5µl of LightCycler 480 SYBR Green I Master
mix (Roche), 10µM forward and reverse primers (0.5µl each),
0.8µl of cDNA (RT mix) and the rest of the volume constituted
with RNase-free water. Each reaction was run in triplicates and
includes the enzyme activation step 95◦C for 4min continued
for 40 times with the following steps: 95◦C for 10 s, 56◦C for
10 s, 72◦C for 10 s. Each run was finished with the melting
curve. Neuron-specific Neurofilament H (Nefh) was used as
the endogenous control gene. Nefh appears over threshold at
Cp 24–25 in our qPCR conditions in all runs. The laboratory
golden standard was the 1:1 mixture of RNAs prepared from the
newborn and 21 day whole brains. This mixture, representing all
the genes analyzed by qPCR, was used as calibrator in every run.
Primer sequences are listed in Supplementary file S2. Three or
four independent experiments were performed. In each repeat,
all genes were analyzed simultaneously on the same PCR run. The
means were statistically analyzed with one-way ANOVA followed
by Tukey-Kramer Multiple Comparisons Test using GraphPad
InStat 3 program (GraphPad Software, Inc., CA, USA).
RESULTS
Microarray Profiling of Gene Expression in
Immature and Mature Sympathetic
Neurons
To reveal the genes that are differently expressed in the immature
and mature SCG neurons the biotin-labeled single-stranded
cDNA samples were hybridized to the Affymetrix GeneChips R©
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Mouse Exon 1.0 ST microarrays. To assess the quality of
data, all experimental groups: immature 5DIV neurons (three
repeats) mature 21DIV neurons (six repeats), 5DIV non-
neuronal cells (one repeat) and 21DIV non-neuronal cells (one
repeat) were subjected to principle component analysis (PCA)
and hierarchical clustering. The PCA-plot (Figure 2) shows that
immature neurons, mature neurons and non-neuronal cells
cluster separately from each other but the repeats within these
groups cluster together. No obvious outliers were detected. The
same conclusions were drawn from hierarchical clustering (not
shown).
The significance of differential expression between 5DIV
and 21DIV neuronal samples, as well as between 5DIV and
21DIV non-neuronal samples was assessed using the empirical
Bayes moderated t-statistics followed by p-value adjustment with
false discovery rate (FDR) approach. Importantly, the genes
that changed significantly in the non-neuronal cells during
3-week culture almost completely differed from those that
changed during 3-week maturation of neurons (not shown). We
therefore conclude that the small number of non-neuronal cells
remaining in the neuronal samples after cell collection could not
significantly affect the interpretation of array data.
In the neuronal samples, of about 26,800 genes analyzed,
2461 changed with adjusted p < 0.05, 1310 of these being up-
regulated and 1151 down-regulated. Table 1 shows the number
of differentially expressed genes with increasingly stringent cut-
off parameters. 39 genes were up-regulated and 30 genes down-
regulated more than log 1.5-fold with adjusted p < 0.01. These
genes are listed in the Tables 2, 3, respectively. Data of the whole
FIGURE 2 | PCA analysis of the samples. PCA-plots show the location of
the samples along the first and second principle component (left) and along
the second and third principle components (right). The second principal
component separates young (5DIV) (yg) and mature (21DIV) (mg) glial cell
samples from the neuronal samples, whereas the third principal component
separates the young (5DIV) (y) and mature (21DIV) (m) neuronal samples.
array are available from the ArrayExpress database (http://www.
ebi.ac.uk/arrayexpress) under accession number E-MTAB-3221.
There were no significant changes in the genes for
classical markers of sympathetic neurons such as th (tyrosine
hydroxylase), ddc (dopa decarboxylase), dbh (dopamine beta
hydroxylase), npy (neuropeptide Y), Eno2 (neuron-specific
enolase), and Slc18a2 (vesicular monoamine transporter 2).
We conclude that the main sympathetic phenotype is already
developed by the first postnatal week.
Gene Ontology Analysis
To reveal the potential functional trends in our data, differentially
expressed genes with adjusted p > 0.05 were associated
with Gene Ontology (GO) terms using web-based DAVID
software (http://david.abcc.ncifcrf.gov/) (Huang da et al., 2007).
Up- and down-regulated genes were analyzed separately. The
most abundantly enriched GO-terms among up- and down-
regulated genes are presented on Tables 4, 5, respectively. The
full cluster analysis is presented in the Supplementary file S1.
Of note, many significantly up-regulated GO-terms were related
to the neurons, confirming purity of our neuronal samples. As
shown in Table 4, the most potently up-regulated GO-terms
during SCG neuronal maturation were associated with neuronal
differentiation, including the neurites, synapses, ion channels,
neurotransmitters etc.
The GO-terms related to epigenetic repression of the genome
and transcription were among the most significantly up-
regulated ones, including the genes involved in chromosome
condensation (Akap8,Cdca5), nuclear chromatin (Phc1,Dnmt3a,
Pcgf2, Sirt7, Hira, H2afy2, Zfp57), histone acetylation (Pcgf2,
Kat6a) and histone methyltransferases (Kmt2b, Nsd1, Whsc1,
Setdb1, Ehmt1, Suv420h2). However, some genes related
to transcriptional repression (histone deacetylases Hdac8,
Hdac9, Hdac11) were down-regulated and some transcriptional
activators (Setd7, Kat6a, Ing5, Ep300) up-regulated.
Functional categories related to cell surface receptors (several
Eph receptors, Alk, Egfr, Igf1r) and their signaling (cellular
response to extracellular stimulus, transmembrane receptor
protein tyrosine kinase activity, PZD domain binding) were
also significantly enriched among the up-regulated genes. Also,
the cell adhesion-related GO-terms were up-regulated during
maturation, including the genes Psen1 (presenilin 1), Neo1
(neogenin1), Ctnna2 (catenin, alpha2), Mllt4, Reln (reelin).
TABLE 1 | Number of significantly up-or down-regulated genes using
different adjusted p-values and log fold changes (logFC).
Up Down
adj p < 0.05 1310 1151
adj p < 0.01 587 461
adj p < 0.05, logFC >1 169 124
adj p < 0.01, logFC >1 121 94
adj p < 0.05, logFC >1.5 58 33
adj p < 0.01, logFC >1.5 39 30
adj p < 0.05, logFC >2 18 11
adj p < 0.01, logFC >2 10 10
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TABLE 2 | Most significantly up-regulated genes in the 21DIV compared
to 5DIV SCG neurons (adjusted p < 0.01, log fold change >1.5).
Gene ID Description log FC adj p-value
Gjc3 Gap junction protein, gamma 3 −3.24 0.011109
Lynx1 Ly6/neurotoxin 1 −3.22 0.000001
Cdk18 Cyclin-dependent kinase 18 −2.79 0.000605
Wls Wntless homolog (Drosophila) −2.39 0.006118
Ajap1 Adherens junction associated protein 1 −2.33 0.013279
Gda Guanine deaminase −2.31 0.000655
Tnfrsf10b Tumor necrosis factor receptor superfamily,
member 10b
−2.29 0.000126
Gria3 Glutamate receptor, ionotropic, AMPA3
(alpha 3)
−2.27 0.000590
Tnr Tenascin R −2.25 0.001291
Vwa5a Von Willebrand factor A domain containing
5A
−2.16 0.000297
Nt5c1a 5′-nucleotidase, cytosolic IA −2.13 0.000883
Cd44 CD44 antigen −2.11 0.007235
Cmbl Carboxymethylenebutenolidase-like
(Pseudomonas)
−2.00 0.000186
Mfge8 Milk fat globule-EGF factor 8 protein −1.99 0.003712
Ano3 Anoctamin 3 −1.99 0.001612
Mybl1 Myeloblastosis oncogene-like 1 −1.98 0.000186
Herc6 Hect domain and RLD 6 −1.97 0.000264
Cast Calpastatin −1.97 0.000186
Ly96 Lymphocyte antigen 96 −1.97 0.000186
Wbscr27 Williams Beuren syndrome chromosome
region 27 (human)
−1.93 0.001612
Ctla2a Cytotoxic T lymphocyte-associated protein
2 alpha
−1.90 0.008117
Ccnd2 Cyclin D2 −1.90 0.011249
170000
7K13Rik
RIKEN cDNA 1700007K13 gene −1.89 0.000034
Bmp7 Bone morphogenetic protein 7 −1.84 0.004110
Gal Galanin −1.84 0.001046
Crebrf CREB3 regulatory factor −1.82 0.003056
Susd2 Sushi domain containing 2 −1.82 0.001636
Hcn1 Hyperpolarization-activated, cyclic
nucleotide-gated K+ 1
−1.80 0.002706
Ell2 Elongation factor RNA polymerase II 2 −1.80 0.001770
Stard13 StAR-related lipid transfer (START) domain
containing 13
−1.73 0.011192
Sh3bgrl2 SH3 domain binding glutamic acid-rich
protein like 2
−1.73 0.000340
Eda2r Ectodysplasin A2 receptor −1.72 0.002128
Ptprm Protein tyrosine phosphatase, receptor
type,M
−1.71 0.009108
Ephx1 Epoxide hydrolase 1, microsomal −1.69 0.000208
Slc41a3 Solute carrier family 41, member 3 −1.66 0.005057
Frmpd4 FERM and PDZ domain containing 4 −1.65 0.003490
Itgb5 Integrin beta 5 −1.64 0.000883
Sulf2 Sulfatase 2 −1.62 0.003117
Mr1 Major histocompatibility complex, class
I-related
−1.59 0.008301
Gbp7 Guanylate binding protein 7 −1.58 0.000330
Slc22a18 Solute carrier family 22 (organic cation
transporter), member 18
−1.57 0.004334
Hist1h2bc Histone cluster 1, H2bc −1.56 0.003142
Rasd2 RASD family, member 2 −1.54 0.000838
TABLE 3 | Most significantly down-regulated genes in the 21DIV
compared to 5DIV SCG neurons (adjusted p < 0.01, log fold change >1.5).
Gene ID Description log FC adj p-value
Slc38a4 Solute carrier family 38, member 4 4.02 0.000186
Agtr2 Angiotensin II receptor, type 2 3.34 0.000126
Dchs1 Dachsous 1 (Drosophila) 3.12 0.000034
Car2 Carbonic anhydrase 2 2.77 0.000007
Coch Coagulation factor C homolog
(Limulus polyphemus)
2.64 0.001140
Shisa6 Shisa homolog 6 (Xenopus laevis) 2.47 0.000264
Crtac1 Cartilage acidic protein 1 2.32 0.001345
Stk32b Serine/threonine kinase 32B 2.19 0.000932
Slc16a12 Solute carrier family 16
(monocarboxylic acid transporters),
member 12
2.13 0.004841
Dcx Doublecortin 2.10 0.000497
Dpp10 Dipeptidylpeptidase 10 2.06 0.014455
B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 5
1.96 0.000374
Zfp57 Zinc finger protein 57 1.94 0.000649
Vwa5b2 Von Willebrand factor A domain
containing 5B2
1.84 0.000264
Igf2bp3 Insulin-like growth factor 2 mRNA
binding protein 3
1.81 0.000828
4833424O15Rik RIKEN cDNA 4833424O15 gene 1.72 0.000520
Gpr119 G-protein coupled receptor 119 1.72 0.000420
BC068157 cDNA sequence BC068157 1.71 0.000186
Gjd2 Gap junction protein, delta 2 1.70 0.013462
St8sia2 ST8 alpha-N-acetyl-neuraminide
alpha-2,8-sialyltransferase 2
1.69 0.001166
Fat3 FAT tumor suppressor homolog 3
(Drosophila)
1.68 0.000186
Nxph4 Neurexophilin 4 1.68 0.000066
Rimklb Ribosomal modification protein
rimK-like family member B
1.67 0.001005
4931428F04Rik RIKEN cDNA 4931428F04 gene 1.64 0.014154
Cacng4 Calcium channel,
voltage-dependent, gamma subunit
4
1.62 0.000186
Peg10 Paternally expressed 10 1.62 0.002032
Crip1 Cysteine-rich protein 1 (intestinal) 1.59 0.001874
Cxadr Coxsackie virus and adenovirus
receptor
1.58 0.000208
Efnb3 Ephrin B3 1.58 0.000186
Trim67 Tripartite motif-containing 67 1.57 0.003034
Enpp2 Ectonucleotide
pyrophosphatase/phosphodiesterase
2
1.57 0.000355
Efcab3 EF-hand calcium binding domain 3 1.54 0.002390
Asic1 Acid-sensing (proton-gated) ion
channel 1
1.50 0.001672
In contrast, many down-regulated GO-terms appeared to be
involved in the various metabolic and biosynthetic processes
(Table 5).
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TABLE 4 | Most significantly enriched GO-terms from the genes up-regulated during maturation of the SCG neurons.
GO-term F.E. p Genes
Protein retention in ER lumen (GO:0006621, BP) 11.4 0.02 Kdelr2, Grik5, Kdelr1
Mitotic chromosome condensation (GO:0007076, BP) 8.2 0.05 Akap8, Cdca5, Atf6b
Dendrite morphogenesis (GO:0048813, BP) 7.9 0.003 Dscam, Cacna1a, Ctnna2, Dcx, Slc11a2
Diacylglycerol metabolic process (GO:0046339, BP) 7.6 0.01 Dgkk, Lipe, Agpat6, Dgkd
Long-term memory (GO:0007616, BP) 7.1 0.06 Chst10, Gria1, Grin1
Ephrin receptor activity (GO:0005003, MF) 6.7 0.005 Ephb2, Epha7, Epha10, Epha6, Epha8
Dendritic shaft (GO:0043198, CC) 6.6 0.005 Cacna1b, Psen1, Asic1, Cacna1c, Slc1a2
Voltage-gated calcium channel activity (GO:0005245, MF) 6.2 6.3E-4 Cacna1b, Cacna1a, Cacna1d, Cacng4, Cacna1i, Cacna1c, Ryr1
UDP-galactosyltransferase activity (GO:0035250, MF) 6.2 0.002 B4galt2, Ugt8a, B4galt3, B3galnt1, B3galt1, B3gat1
Retinal ganglion cell axon guidance (GO:0031290, BP) 5.4 0.03 Bmpr1b, Ephb2, Epha7, Isl1
Ionotropic glutamate receptor complex (GO:0008328, CC) 5.3 0.04 Gria1, Grin1, Grik5, Dlg4
Histone-lysine N-methyltransferase activity (GO:0018024, MF) 5.0 0.002 Kmt2b, Nsd1, Whsc1, Setdb1, Ehmt1, Suv420h2, Setd7
Regulation of long-term neuronal synaptic plasticity (GO:0048169, BP) 5.0 0.02 Ephb2, Rims1, Grin1, Dlg4, Nras
Cerebral cortex cell migration (GO:0021795, BP) 4.8 0.05 Reln, Psen1, Egfr, Lrp8
Cell adhesion molecule binding (GO:0050839, MF) 4.7 0.05 Psen1, Neo1, Ctnna2, Mllt4
Neuropeptide receptor activity (GO:0008188, MF) 3.9 0.004 Npffr2, Prlhr, Galr1, C130060K24Rik, Npffr1, Ntsr2, Npy1r, Npy5r
Regulation of axonogenesis (GO:0050770, BP) 3.9 0.004 Mapt, Ephb2, Lrrc4c, Psen1, Plxna3, Grin1, Plxnb1, Cacna1a
Cellular response to extracellular stimulus (GO:0031668, BP) 3.8 0.002 Eif2ak4, Tnrc6a, Angptl4, Fos, Psen1, Ppan, Atg16l1, Atf6b, Slc1a2
PDZ domain binding (GO:0030165, MF) 3.7 0.04 Atp2b2, Lpar2, Grik5, Kirrel3, Igsf5
Protein amino acid glycosylation (GO:0006486, BP) 3.6 1.8E-5 St8sia2, Pomt2, B3gnt6, Slc4a10, Rpn2, B3galt1, Dolpp1, Fut8,
St6galnac3, Trak1, Psen1, B3gnt5, B3galnt1, Rpn1, B3gnt9, St8sia6,
St6gal2
Nuclear chromatin (GO:0000790, CC) 3.4 0.003 Phc1, Dnmt3a, Pcgf2, Sirt7, Hira, Akap8, H2afy2, Smarcb1, Zfp57,
Tcf3
Transmembrane receptor protein tyrosine kinase activity (GO:0004714, MF) 3.3 0.003 Pcgf2, Ephb2, Epha7, Epha10, Epha6, Alk, Egfr, Epha8, Kit, Igf1r
Histone acetylation (GO:0016573, BP) 3.3 0.03 Pcgf2, Kat6a, Ing5, Ep300, Mbd3, Tcf3
Neurotransmitter secretion (GO:0007269, BP) 3.2 0.04 Cacna1b, Lin7c, Psen1, Cacna1a, Unc13b, Sv2b
Glycoprotein biosynthetic process (GO:0009101, BP) 3.1 3.7E-5 St8sia2, Pomt2, B3gnt6, Slc4a10, Rpn2, Large, B3galt1, Dolpp1,
Fut8, St6galnac3, Trak1, Psen1, Ext1, B3gnt5, B3galnt1, Rpn1,
B3gnt9, St8sia6, St6gal2
Shown are the non-redundant GO-terms with numerical identifiers and the domains Biological Process (BP), Molecular Function (MF) or Cellular Component (CC), the fold enrichment
(F.E.), p-value and the included genes.
Analysis of the Cell Death- and
Survival-Related Genes
The ending of PCD is a remarkable event during maturation
of the SCG neurons. It is genetically determined (Easton et al.,
1997; Francis and Landis, 1999; Putcha et al., 2000; Glebova
and Ginty, 2005; Young et al., 2011) but very little is known
about its mechanisms and the involved genes (Kole et al.,
2011). We therefore paid special attention to the changes in the
genes related to cell death and survival. Gene ontology cluster
analysis (Supplementary file S1) revealed the GO-terms related
to apoptosis and cell death among the down-regulated genes
(Table 6) but not among up-regulated genes.
We analyzed changes in the genes known to be essential in the
survival or death of the sympathetic or other neurons. Only few
of those were significantly changed. Genes for the neurotrophic
factors related to sympathetic neurons Ngf, Bdnf, Ntf3 (NT3),
Gdnf, Nrtn, Artn and their respective receptors Ntrk2 (TrkB),
Ntrk3 (TrkC), Ret, Ngfr (p75NTR), Gfra1, Gfra1, and Gfra3
were not significantly changed during neuronal maturation.
Surprisingly, the gene for NGF receptor Ntrk1 (TrkA) was
missing from the array. However, activated (phosphorylated)
TrkA was shown to be more stable in the mature than immature
sympathetic neurons (Tsui-Pierchala and Ginty, 1999) that could
contribute to the insensitivity of mature neurons to NGF
for survival. We therefore checked the genes reported to be
associated with TrkA, such as Appl1 and Gipc1 (Lin et al., 2006),
Slc9a5 (Diering et al., 2013), Ccm2 (Harel et al., 2009), Stk25
(Costa et al., 2012), Kidins220 (ARMS) (Sniderhan et al., 2008),
Ptpn6 (SHP1) (Marsh et al., 2003), Jakmip2 (Necc2) (Díaz-Ruiz
et al., 2013), Pincher (Shao et al., 2002), and Cox (cytochrome
oxidase) genes (Vaughn and Deshmukh, 2008). All these genes
were not significantly changed, suggesting that regulation of the
activity of TrkA could not be the main cause why the mature
neurons survive without NGF. However, the levels of Ptpn11,
encoding for the phosphatase SHP2 and reported to regulate
positively the signaling of TrkB receptors (Araki et al., 2000;
Takai et al., 2002), had slightly increased in the mature neurons
(Table 4). The genes reported to interact with p75NTR (Roux and
Barker, 2002) such as Sort1 (sortilin), Traf6, Maged1 (NRAGE),
Zfp110 (NRIF), Ngfrap1 (NADE), and Ndn (Necdin) were also
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TABLE 5 | Most significantly enriched GO-terms from the genes down-regulated during maturation of the SCG neurons.
GO-term F.E. p Genes
DNA replication, synthesis of RNA primer (GO:0006269, BP) 12.4 0.02 Ccdc111, Helb, Prim1
Glycolipid catabolic process (GO:0019377, BP) 11.1 0.004 Hexa, Hexb, Galc, Gla
Arylsulfatase activity (GO:0004065, MF) 9.8 0.03 Arsb, Arsg, Sulf2
Phosphatidylinositol metabolic process (GO:0046488, BP) 6.0 0.02 Cd81, Pip4k2c, Pip4k2a, Pip5k1b
Nucleotide kinase activity (GO:0019201, MF) 5.8 0.009 Ak5, Mpp5, Ak8, Ak1, Cmpk1
Branched chain family amino acid metabolic process (GO:0009081, BP) 5.5 0.01 Auh, Bckdha, Ghr, Aldh6a1, Acad8
Oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as
acceptor (GO:0016628, MF)
5.4 0.01 Decr1, Pecr, Blvrb, Dpyd, Ptgr1
Aromatic compound biosynthetic process (GO:0019438, BP) 5.2 0.01 Pts, Mocs1, Spr, Gch1, Pcbd1
Protein homotetramerization (GO:0051289, BP) 5.1 0.04 H2-D1, Hprt, Gpx3, Pcbd1
Palmitoyltransferase activity (GO:0016409, MF) 4.8 0.02 Cpt1a, Cpt1c, Cpt2, Zdhhc1, Zdhhc15
Glycolipid metabolic process (GO:0006664, BP) 4.5 0.009 Hexa, Hexb, Galc, Gla, St6galnac6, Map7
Dopamine metabolic process (GO:0042417, BP) 4.4 0.02 Sncb, Park2, Hprt, Spr, Nr4a2
Purine nucleoside metabolic process (GO:0042278, BP) 4.1 0.01 Pcmt1, Hprt, Nudt7, Mat2b, Ocln, Ppcdc
Acetyl-CoA catabolic process (GO:0046356, BP) 4.1 0.01 Mdh1, Sdha, Nudt7, 2610507B11Rik, Sucla2, Idh3b
Negative regulation of DNA metabolic process (GO:0051053, BP) 4.1 0.03 Ndfip1, Msh6, Brca2, Bcl6, Msh2
Shown are the non-redundant GO-terms with numerical identifiers and the domains Biological Process (BP), Molecular Function (MF) or Cellular Component (CC), the fold enrichment
(F.E.), p-value and the included genes.
TABLE 6 | GO-terms related to cell death or apoptosis that were significantly down-regulated during maturation of the SCG neurons.
GO-term F.E. p Genes
Death (GO:0016265, BP) 1.7 3.7E-4 Fkbp8, Cdip1, Slk, Xaf1, 4632434I11Rik, Ggct, Rassf5, Spr, Msh2, Cyfip2, Cib1,
Gatad2a, Lrdd, Asah2, Bag3, Itgb3bp, Gan, Pura, Naip2, Prune2, Bnip3l, Sqstm1,
Eda2r, Gulp1, Unc5a, Bcap29, Ypel3, Tax1bp1, Perp, Unc5b, Bcl2l13, Itm2b, Cflar,
Rad21, Aktip, Hprt, Nr4a2, Rnf144b, Phlda3, Trp53inp1, Ift57, Ebag9, Wwox, Zmat3,
Mef2a, Faim2, Ppm1f, Triap1, Ppt1, Stk3, Tnfrsf10b, Pea15a
Programmed cell death (GO:0012501, BP) 1.7 4.9E-4
Cell death (GO:0008219, BP) 1.6 6.9E-4
Apoptosis (GO:0006915, BP) 1.6 0.001
Regulation of apoptosis (GO:0042981, BP) 1.5 0.003 Msh6, S100b, Cdip1, Scg2, Eef1a2, Bcl6, Wrn, Nol3, Ddit3, Foxo1, Cdkn1a, Msh2,
Sncb, Zak, Mitf, Bag3, Aifm2, Rarb, Glo1, Brca2, Snai2, Bnip3l, Tax1bp1, Perp,
Gch1, Apoe, Serinc3, Bcl2l13, Itm2b, Adora1, Cflar, Efhc1, Gal, Bmp7, Nr4a2,
Sycp3, Phlda3, Trp53inp1, Ift57, Jmy, Wwox, Nr3c1, Sgk3, Xrcc4, Triap1, Ppt1, Stk3,
Gfral, Xrcc5, Tnfrsf10b, Pea15a
Regulation of programmed cell death (GO:0043067, BP) 1.5 0.003
Regulation of cell death (GO:0010941, BP) 1.5 0.003
Positive regulation of programmed cell death (GO:0043068, BP) 1.6 0.03
Positive regulation of cell death (GO:0010942, BP) 1.6 0.03
Negative regulation of apoptosis (GO:0043066, BP) 1.6 0.03
Negative regulation of programmed cell death (GO:0043069, BP) 1.6 0.04
Anti-apoptosis (GO:0006916, BP) 2.1 0.04
Negative regulation of cell death (GO:0060548, BP) 1.6 0.04
Positive regulation of apoptosis (GO:0043065, BP) 1.5 0.04
Shown are the GO-terms with numerical identifiers, all belonging to the domain Biological Process (BP), the fold enrichment (F.E.) and the p-value. The indicated genes are associated
with all respective GO-terms, albeit at different extent.
not significantly changed. In conclusion, the independence of
the mature SCG neurons from NTFs for survival seems not to
be caused by changes in the levels of NTFs, their receptors and
known receptor-interacting proteins.
Among the genes for the core apoptotic machinery proteins,
including Bcl-2 family members, caspases, Birc (IAP) family
members, but also death receptors, their ligands and the
proteins of death-inducing signaling complex (DISC) only few
changed significantly upon neuronal maturation (Table 7). The
proapoptotic protein Bax is critical for the PCD of SCG neurons
(Putcha et al., 1999), as in its absence or upon its blockage
the neurons do not die by NGF deprivation (Deckwerth et al.,
1996; Aalto et al., 2007). As Bax protein is present but not
activated by NGF deprivation in the mature SCG neurons
(Easton et al., 1997; Putcha et al., 2000; Kole et al., 2011)
we analyzed the reported genes for Bax-interacting proteins,
such as Xrcc6 (Ku70) (Sawada et al., 2003), mt-Rnr2 (humanin)
(Guo et al., 2003), all Ywha (14-3-3) genes (Samuel et al.,
2001), Sh3glb1 (Bif-1, endophilin B1) (Wang et al., 2014), Pin1
(Shen et al., 2009), Clu (clusterin) (Zhang et al., 2005), Npm1
(nucleophosmin) (Kerr et al., 2007), Cfl1 (cofilin) (Simonishvili
et al., 2013), Tmbim genes (Rojas-Rivera and Hetz, 2014), and
Nelfb (Cobra-1) (Ichim et al., 2013) and found that these were not
significantly changed during neuronal maturation (except slight
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TABLE 7 | Genes related to apoptosis or cell survival that changed significantly during SCG neuronal maturation.
Gene ID Description log FC adj p-value References
Tnfrsf10b Tumor necrosis factor receptor superfamily, member 10b [TRAIL-R2/DR5] −2.29 0.00013 Kichev et al., 2014
Faim2 Fas apoptotic inhibitory molecule 2 −0.84 0.0006 Segura et al., 2007; Yu et al., 2008
Traf4 TNF receptor associated factor 4 1.06 0.0014
Traf7 TNF receptor-associated factor 7 0.51 0.005
Bak1 BCL2-antagonist/killer 1 [N-Bak] 0.35 0.032 Sun et al., 2001; Jakobson et al., 2012, 2013
Bcl2l13 BCL2-like 13 (apoptosis facilitator) [Bcl-rambo] −0.25 0.042 Kataoka et al., 2001
Bnip3l BCL2/adenovirus E1B interacting protein 3-like [Nix] −0.39 0.033 Zhang and Ney, 2009
Xaf1 XIAP associated factor 1 −0.71 0.0007 Perrelet et al., 2004
Aifm2 Apoptosis-inducing factor, mitochondrion-associated 2 −0.25 0.049 Hangen et al., 2010
Akt3 Thymoma viral proto-oncogene 3 −0.42 0.0031
Mapk7 Mitogen-activated protein kinase 7 [Erk5] 0.51 0.0091
Mapk6 Mitogen-activated protein kinase 6 [Erk3] 0.45 0.014
Mapk3 Mitogen-activated protein kinase 3 [Erk1] −0.27 0.036
Ptpn11 Protein tyrosine phosphatase, non-receptor type 11 [SHP2] −0.45 0.010 Araki et al., 2000
Klf9 Krüppel-like factor 9 −1.23 0.0017 Lebrun et al., 2013
Nr1d1 Nuclear receptor subfamily 1, group D, member 1 −1.04 0.0002 Chomez et al., 2000
Bcl6 B cell leukemia/lymphoma 6 −1.11 0.0002 Otaki et al., 2010
Foxo1 Forkhead box O1 −0.88 0.003 Gilley et al., 2003
Tmbim1 Transmembrane BAX inhibitor motif containing 1 −0.71 0.002 Rojas-Rivera and Hetz, 2014
TABLE 8 | Genes selected from the microarray for qPCR analysis.
Gene ID Description log FC adj p-value
Igf2bp3 Insulin-like growth factor 2 mRNA
binding protein 3
1.81 0.000828
Zfp57 Zinc finger protein 57 1.94 0.052627
Dcx Doublecortin 2.10 0.000497
Coro1a Coronin, actin binding protein 1A 0.93 0.052746
Apaf1 apoptotic peptidase activating factor 1 0.71 0.095022
increase in Tmbim1). Only few genes for classical cytoplasmic
kinases whose activity could promote cell survival changed
significantly during neuronal maturation (Table 7), whereas, e.g.,
Map3k11 (MLK3),Mapk8 (Jnk1),Mapk9 (Jnk2), Akt1, and Akt2,
but also phosphatase Dusp1 (Mkp1) (Kristiansen et al., 2010)
remained unchanged. Thus, the levels of the members of core
apoptotic machinery or classical survival-promoting kinases are
not drastically changed during SCG maturation. The mRNA
levels of several transcription factors reported to be related to
neuronal maturation or apoptosis, such as Trp73 (p73) (Walsh
et al., 2004), Trp53 (p53) (Vaughn and Deshmukh, 2007), Jun
(Easton et al., 1997; Ham et al., 2000) did not change significantly
upon neuronal maturation. However, Nr1d1 (Chomez et al.,
2000), Bcl6 (Otaki et al., 2010), Foxo1 (Gilley et al., 2003), and
Klf9 (Lebrun et al., 2013) transcripts were all significantly up-
regulated in the mature neurons.
We were surprised to find that core apoptotic machinery
was basically not changed in the neurons whose PCD was
over. To confirm this finding we analyzed the array data
also with Gene Set Enrichment Analysis (GSEA) another web-
based method that uses the whole gene sets to interpret the
array data and is therefore useful to test specific hypotheses
(Supplementary files S3, S4). No gene sets related to apoptosis
and cell death were revealed in the young neurons, whereas
11 were found in the mature neurons that, however had very
high normalized p-values and FDR’s (Supplementary file S4) and
are most likely false positives. Thus, also GSEA did not reveal
significant changes in the classical apoptotic genes in the mature
neurons.
qPCR Analysis of Selected Genes in the
Immature and Mature Sympathetic Ganglia
Isolated From Mouse and Rat
As an example of the usage of array data we selected five genes
of interest: Igf2bp3, Coro1A, Zfp57, Dcx, and Apaf (Table 8) that
could potentially be involved in the neuronal maturation and
whose expression changes were also revealed by the microarray.
Expression of these genes was analyzed by qPCR in the immature
and mature ganglia from two species—mouse and rat. To gain
insight whether gene expression changes obtained from in vitro
cultures reflect the situation in vivo, total RNA from freshly
prepared whole ganglia from the newborn, 2 and 3 weeks old
mice and rats were analyzed. The data were normalized to the
Nefh (neurofilament heavy polypeptide) gene that is expressed
only in the neurons and whose expression level did not change
significantly in the SCG during the analyzed time points (see the
Materials and Methods).
The results are presented on Figure 3. The mRNAs for
Igf2bp3, Coro1A, Zpf57, and Dcx were drastically reduced by
second week of postnatal development in both animal species,
and very low levels of these genes persisted by third postnatal
week. All these genes were also significantly down-regulated
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FIGURE 3 | qPCR analysis of the selected genes during maturation of rat SCG. Shown are the relative mRNA quantifies (RQ) from newborn (1D), 2 weeks (2W)
and 3 weeks (3W) old rat and mouse SCG, normalized to the levels of Nefh and calibrated against the laboratory golden standard. Three independent analyses
(except four for rat Apaf1) were performed and the means were compared with one-way ANOVA followed by Tukey-Kramer Multiple Comparisons Test. Shown are the
means ± S.E.M. *p < 0.05; **p > 0.01, ***p > 0.001. The null hypothesis was rejected at p < 0.05.
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in the microarray assay (Table 8). Apaf1 mRNA was also
significantly down-regulated in the mature neurons as reported
by others (Wright et al., 2007), although the change was less
significant in the microarray. Thus, the changes in these selected
genes determined by microarray in the cultured neurons mostly
matched the changes determined by qPCR from the whole
ganglia.
DISCUSSION
In this study we compared the gene expression profiles of
immature and mature sympathetic neurons to get first insight
of the poorly studied processes of maturation, including the
control of PCD (Kole et al., 2013; Lebrun et al., 2013). To our
knowledge, the current analysis is the first one performed on the
immature and mature SCG neurons. Many changes that occur
during neuronal maturation are permanent, suggesting stable
changes in the gene expression. Therefore, our analysis, deposited
to the public database, could be a valuable source in the studies of
neuronal maturation.
The majority of mouse and rat SCG neurons exit the cell cycle
before birth (Hendry, 1977; Shi et al., 2008). Thus, in the neonatal
mouse ganglia most of the dividing cells are glial progenitors
that give rise to the satellite cells, except a small population
of the neurons that became postmitotic during first postnatal
week (Shi et al., 2008). The neuritogenesis, target innervation
and synaptogenesis of the sympathetic neurons also begin in
the embryogenesis but occur mostly during postnatal maturation
(De Champlain et al., 1970; Schotzinger and Landis, 1990). This
correlates well with our GO analysis showing enrichment of
the GO terms related to neurite maturation, synaptic plasticity,
neuronal migration, ion channels and neurotransmitter receptors
in the mature neurons. Also, the main known markers for the
sympathetic neurons (th, ddc, dbh, npy, Eno2, Slc18a2) did not
change significantly during maturation, showing that the basic
sympathetic phenotype was already established in the mice by
birth.
Many GO-terms concerning the modification of chromatin
and regulation of transcription were significantly up-regulated
showing that the postnatal maturation of the sympathetic ganglia
involves epigenetic regulation of gene expression that could be
the last steps of terminal differentiation. Most of the genes in
these GO-terms have been related to chromatin condensation
and gene repression, suggesting that in the mature neurons,
chromatin is more repressed than in the immature ones.
However, some transcriptional repressors were down-regulated
and some transcriptional activators up-regulated, suggesting
that some genes are also activated during maturation. The
GO-terms related to cell surface receptors, their signaling and
cell adhesion molecules were also significantly enriched in the
mature neurons, suggesting that extracellular signaling and
increased cell adhesion play important role in the maturation
of SCG neurons. The most significantly down-regulated GO-
terms included genes that are related to the metabolic and
biosynthetic processes. It is difficult to conclude from the
GO-terms the details of the metabolic changes and we
therefore conclude only that the metabolic activity is high in
the neonatal SCG neurons but could decrease during their
maturation.
The end of PCD is a remarkable event in the postnatal
maturation of the SCG neurons that occurs largely via
intrinsically determined genetic events rather than the
extracellular signals, as it appears in the dissociated cultures
with similar time schedule as in the whole ganglia in vivo
(Easton et al., 1997; Francis and Landis, 1999; Putcha et al., 2000;
Glebova and Ginty, 2005; Young et al., 2011). We therefore
paid special attention to the genes related to cell survival and
death. Individual checking of the classical genes for apoptosis
or cell survival did not reveal major changes in their levels
during neuronal maturation, except Apaf1 that was clearly
reduced, as also reported by others (Wright et al., 2007). This
conclusion was supported by alternative GSEA method that also
did not reveal significant changes in the apoptotic and cell death
related gene sets. Active killing of the neurons via neurotrophin
receptor p75NTR (Deppmann et al., 2008; Hempstead, 2014)
or dependence receptors such as Ret (Bordeaux et al., 2000)
or TrkC (Tauszig-Delamasure et al., 2007) but also TrkA
(Nikoletopoulou et al., 2010) could contribute to neuronal PCD.
However, these receptors and the proteins known to associate
with them were not significantly down-regulated in the mature
SCG neurons and might not be the major mechanism of the
NGF-independency. Low levels of Apaf1 (Wright et al., 2007),
this study, and repression of transcripts for some Bax-activating
BH3-only proteins (Bim, DP5/Hrk, PUMA) by microRNAs in
the mature SCG neurons (Kole et al., 2011) certainly contribute
to their independence of NGF for survival. However, additional
yet to be discovered genes/proteins could be involved in the
termination of PCD that is a major process crucially changing
the status of the neuron (Kole et al., 2013). Our cluster analysis
revealed significant enrichment of the GO-terms related to
cell death and apoptosis among down-regulated genes, but
not up-regulated genes, suggesting general suppression of the
apoptotic program. Notably the apoptotic functions of most of
the genes associated with these GO-terms are currently poorly
characterized. We propose that the end of PCD is mediated by
yet to be found genes whose products control the activity of
apoptotic machinery.
Our microarray data offer a good choice to select the
candidate genes for the further studies of neuronal maturation.
In this study we selected some genes of interest and studied
their expression changes in the immature and mature SCG
by qPCR. The selected genes changed significantly during
neuronal maturation, were revealed by the gene ontology
analysis and could potentially participate in this process,
but their role in the cell death and neuronal maturation is
currently poorly studied. The genes were analyzed in vivo
by using neuronal marker gene Nefh as a reference to
overcome the confounding effect of non-neuronal cells present
in the ganglia but mainly removed from the neuronal cultures
used for the microarray analysis. The expression changes of
the selected genes analyzed from the in vitro cultures by
microassay and from the whole ganglia by qPCR principally
matched. We want to stress, however, that such match is
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not quaranteed, as the culture conditions may change gene
expression. E.g., much smaller down-regulation of the Apaf1
gene was revealed by microarray than by qPCR in our study.
How the culture conditions affect gene expression in the
SCG neurons is currently poorly known and warrants further
studies.
Igf2bp3 (insulin-like growth factor 2 mRNA binding protein
3) is an RNA-binding protein, involved in the RNA synthesis,
metabolism and stability in different cells including the
neurons (Mori et al., 2001). Coro1A, a cytoskeleton binding
protein, was shown to bind and regulate TrkA-NGF-containing
signaling endosome and thereby increase the survival of
the SCG neurons (Suo et al., 2014). We analyzed Dcx
(doublecortin), a microtubule-associated protein expressed
by migrating immature neurons but down-regulated during
neuronal maturation (Francis et al., 1999; Gleeson et al., 1999),
and found that it was down-regulated also in the mature SCG.
Down-regulation of the mRNA for Apaf1 (apoptotic peptidase
activating factor 1) in the mature SCG (Wright et al., 2007) was
confirmed here as well. Two transcription factors were selected
for further analysis. Zfp57 (zinc finger protein 57) is related to
genomic methylation imprinting (Zuo et al., 2012). Our analysis
of genes expressed differently in the immature and mature
sympathetic neurons could provide a good candidate gene list
for further studies addressing the genetic program governing the
maturation of neurons.
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